Infant Bacterial Therapeutics AB (IBT-B.ST) Q4 2025 Earnings

13NovConfirmed
Q3 2024
Q4 2024
Q1 2025
Q4 2025
-0.75
-0.41
-0.08
0.25

Details

Expected EPS
N/A
Actual EPS
-0.74708981775
Surprise EPS
-0.75
Surprise Percent
+∞%

Description

Infant Bacterial Therapeutics AB (IBT-B.ST) has reported earnings of -0.74708981775 per share for Q4 2025.

0 Comments

Share your thoughts